Unravelling immune system function, one cell at a time
Cellply launches its end-to-end single cell potency characterization platform VivaCyte®
During Advanced Therapies Week 2024 in Miami we officially launched our flagship product, VivaCyte®.
Our platform integrates multiple technologies to streamline cell therapy discovery and development.
Read the press release to find out more details!
Introducing the VivaCyte platform
VivaCyte enables the characterization of immune cells at an unprecedented resolution and scale, with a fully automated analysis, from sample preparation to image processing.
- 100+ samples per run
- 1,000+ single cells per sample
- many assays per cell